SEVEN EIGHT CAPITAL, LP - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 303 filers reported holding BLUEBIRD BIO INC in Q4 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q1 2021$623,0000.0%14,4060.0%0.14%
+0.7%
Q4 2020$623,000
+126.5%
14,406
+182.1%
0.14%
+140.7%
Q3 2020$275,000
-84.0%
5,106
-59.2%
0.06%
-71.9%
Q3 2017$1,718,000
+1490.7%
12,511
+393.5%
0.21%
+356.5%
Q1 2016$108,000
-40.0%
2,535
+20.7%
0.05%
-70.7%
Q3 2015$180,000
+429.4%
2,100
+950.0%
0.16%
+292.5%
Q2 2015$34,000
-29.2%
200
-50.0%
0.04%
-50.0%
Q1 2015$48,000
-75.1%
400
-81.0%
0.08%
-75.1%
Q4 2014$193,0002,1000.32%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2017
NameSharesValueWeighting ↓
AlpInvest Partners B.V. 46,264$3,958,0007.80%
RTW INVESTMENTS, LP 151,594$12,969,0004.03%
APIS CAPITAL ADVISORS, LLC 30,870$2,640,0003.65%
Parametrica Management Ltd 4,084$349,0002.20%
Eventide Asset Management 419,600$35,897,0002.09%
RA Capital Management 167,367$14,318,0002.06%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 483,000$41,321,0001.60%
Taylor Wealth Management Partners 38,184$3,267,0001.58%
Orbimed Advisors 1,188,900$101,710,0001.03%
CABOT WEALTH MANAGEMENT INC 34,195$2,925,0000.81%
View complete list of BLUEBIRD BIO INC shareholders